What Is the OMOP Data Model? Guide for Clinical Research

Modern-day clinical studies require real-world data that is generated from the EHR system, insurance claims, registries, etc. But healthcare data that is collected in one form can hardly be used by other people due to different coding, structure, and data formats in different systems. OMOP Common Data Model (CDM) attempts to overcome this problem through the creation of a standard format for structuring observational health data. The standardization process includes the application of vocabularies for the translation of source-specific codes into the same clinical concepts. The combination of a common data structure and standard vocabularies increases comparability of observational data collected from various sources.

In this guide, you will find information on what the OMOP data model is and what the OMOP Common Data Model structure is. According to a peer-reviewed paper, the OHDSI network had over 331 data sources, 2.1 billion patient records, and 34 countries, utilizing OMOP CDM for data standardization.

What Is the OMOP Data Model?

When answering this question directly, one should say that the OMOP (Observational Medical Outcomes Partnership) Common Data Model is an open and standardized data model intended primarily for data analytics and observational research in the field of healthcare. OMOP CDM allows structuring different kinds of healthcare data, collected by various means, such as electronic health records (EHR), administrative claims, and other sources. OMOP CDM also supports standardized vocabularies that make it possible to map source-specific clinical codes to unified clinical concepts and thus to make data from various databases comparable and fit for research purposes.

As can be inferred from the name of the model, its history is inseparably connected with it. OMOP CDM was developed as a result of the Observational Medical Outcomes Partnership – a public–private collaboration that was launched in 2008 as a reaction to concerns about drug safety. The initiative was aimed at investigating the potential of using observational healthcare databases for drug safety signal detection

Why the OMOP Data Model Was Created

1. Prior to the introduction of the OMOP Common Data Model (CDM), there was a problem of data integration when researchers performed multiple database or multiple institution observational studies. Different health care systems, electronic health record vendors, and claims databases had various ways of organizing and coding information. For instance, a diagnosis could be coded using ICD-9 codes in one database, ICD-10 codes in another database, and proprietary codes in yet another database. Analyzing the same research questions using several databases could therefore imply database-specific data extraction, transformation, and analysis.
2. The OMOP was initially created within the field of pharmacovigilance; its first task was to establish whether the observational health care databases could be used for the detection and evaluation of drug safety signals. However, while evolving, the OMOP/OHDSI community started using the Common Data Model for a variety of purposes related to observational health care research and analytics, including comparative effectiveness and safety studies, disease characterization, population-level estimation, and patient-level prediction.

The two-component standardization framework of the OMOP CDM is as follows:

3. Standardized relational database structure – A common set of tables, fields, and relationships into which healthcare databases could be mapped regardless of their original organization.
4. Standardized vocabularies – A collection of standard clinical terms and mappings, including recognized vocabularies like SNOMED CT, RxNorm, and LOINC, that will assist in the consistent representation of clinical data.

OMOP Common Data Model serves as a framework for organizing healthcare observations in a structured way. OMOP Standardized Vocabularies are used to standardize the meaning of codes in each source. The group that develops and employs the OMOP CDM, vocabularies, and techniques for observational healthcare research is called OHDSI (Observational Health Data Sciences and Informatics).

When data have been mapped to the OMOP CDM, standardized analysis code can usually be used in several databases. It is crucial to note, though, that OMOP does not mean that researchers do not have to know anything about the data underneath. There must be a proper evaluation of local characteristics of the data, ETL decisions, vocabulary mappings, and data quality before interpretation. The difference is significant since OMOP was created for pharmaco-vigilance, but now it is used for reproducible observational research in healthcare.

Core Structure of the OMOP Common Data Model

The OMOP Common Data Model is currently at version 5.5, which OHDSI recommends for new implementations, while the v6 series is being prepared for broader support. Examples of key OMOP CDM tables include:

• PERSON – demographic data about patients
• VISIT_OCCURRENCE – data about visits (inpatient, outpatient, or emergency)
• CONDITION_OCCURRENCE – diagnosis and other clinical conditions observed during the medical care
• DRUG_EXPOSURE – medications that were prescribed, dispensed, or used by the patients
• PROCEDURE_OCCURRENCE – clinical procedures
• MEASUREMENT – laboratory values, vitals, and other numeric clinical data
• OBSERVATION – non-numeric clinical facts
• DEATH – mortality information, if available

Clinical events are represented using standardized OMOP concepts in the relevant fields, while source values and source concepts can also be retained to preserve the original coding information and support data-quality and provenance needs. That is how it becomes possible to query "all patients with type 2 diabetes" using the same standardized vocabulary despite the differences in coding in their source systems.

The OMOP Data Model vs. Traditional Data Standardization Approaches

Aspect	Traditional Source-Specific Data	The OMOP Data Model
Structure across databases	Varies by system/vendor	Standardized relational schema
Clinical vocabulary	Native/proprietary coding	Mapped to standardized vocabularies (SNOMED, RxNorm, LOINC)
Multi-site research	Requires custom ETL per site	Initial ETL per site, with ongoing maintenance; reusable analytics
Analytical code reusability	Low - rebuilt per dataset	High - same code runs across mapped databases
Governance	Proprietary or ad hoc	Open, community-governed via OHDSI
Patient-level data sharing	Often required for pooled analysis	Federated analysis possible without sharing raw patient data

Why the OMOP Data Model Matters for Clinical Research

1. This enables researchers to conduct large-scale analyses across multiple databases and healthcare systems, potentially increasing sample size, diversity, and the generalizability of findings when the underlying data and study design are appropriate.

2. Federated research is possible through the OMOP data model. One of the most valuable advantages of the OMOP data model is the possibility of conducting federated network studies. This approach can allow participating sites to retain patient-level data locally and return aggregate results, reducing the need to share raw patient-level data and helping sites address applicable data-governance requirements.

3. It ensures higher reproducibility. Due to the standardization of structure and vocabulary provided by the OMOP common data model, the analytical code developed for one database can, in theory, be validated and replicated in other OMOP-formatted databases.

4. Speeds up the development of real-world evidence (RWE). Real-world evidence has been a growing concern for regulatory agencies such as the FDA in the realm of drug safety surveillance, label expansion, and post-market surveillance. The OMOP data model is therefore a robust basis for developing real-world evidence efficiently.

5. Provides an ecosystem of open-source tools.OHDSI provides several open-source tools based on the OMOP data model. Some of them include ATLAS for cohort identification and analysis, ACHILLES for characterizing data, and WhiteRabbit/Usagi for ETL and Vocabulary mapping, among others.

Real-World Applications of the OMOP Data Model

The OMOP data model has evolved significantly from being confined to use in pharmacovigilance applications and is now employed extensively in the following types of clinical research:

• Drug safety monitoring – identifying and analyzing adverse drug events across large observational databases

• Comparative effectiveness research – conducting comparisons across different therapies on patient populations, supplementing randomized controlled trial information

• Studies on disease natural history – studying progression of diseases in large and heterogeneous patient populations

• COVID-19 research – large-scale projects, including national research collaborations, have embraced the OMOP data model to facilitate multi-site analyses during the course of and post-pandemic era

• Predictive modeling and machine learning – owing to its structured nature, the OMOP data model is well-suited for developing and validating clinical prediction models across several data sets

• Health outcomes and epidemiology – for conducting research at the population level regarding disease prevalence, incidence, and risk factors

Common Challenges in Implementing the OMOP Data Model

Though there are many benefits, it is also necessary for organizations using the OMOP data model to consider some of the typical problems encountered during the implementation of this methodology:

• ETL complexity. The process of converting the source data according to the structure and standardized vocabulary of the OMOP data model is very complicated, especially in cases where source data is complex and not standard.

• Gaps in vocabulary mapping. There may not be any available standardized concept corresponding to the source concept, and hence custom mapping becomes necessary.

• Dependence on data quality. Though the OMOP data model offers structure standards, it does not help improve the source data quality. Thus, even if the source documentation is incomplete or inaccurate, the OMOP-formatted dataset will be the same.

• Maintenance. As source systems evolve their coding standards and as new versions of the OMOP CDM are developed, the mapped datasets have to undergo constant maintenance.

• Data provenance and missingness: The team must document the origin and the transformation process of the data and any missing information.

• Differences in capturing clinical data: Differences in documentation processes and coding may influence the representation of the clinical events.

• Unstructured clinical notes: Unstructured free-text data usually needs natural language processing to validate the information that is extracted into the OMOP format.

• Source-data quality: OMOP formats data in a consistent way but does not solve issues with inaccurate or incomplete source data.

The Growing Role of AI Alongside the OMOP Data Model

AI and machine learning are increasingly being explored and applied alongside OMOP-based data infrastructure, including vocabulary mapping, NLP-based clinical concept extraction, cohort discovery, phenotyping, and predictive modeling.

• AI-assisted ETL and vocabulary mapping can assist in finding potential matches for standard concepts in the source data, making the vocabulary mapping process easier but not completely automatic and requiring professional validation.

• The application of NLP for extracting structured clinical concepts from unstructured clinical notes is a good solution for making additional data available to be mapped into the OMOP data model.

• AI-assisted cohort discovery and phenotyping solutions are developed on the basis of the OMOP-formatted data and make it easier for researchers to find patient cohorts that meet the specific criteria.

This is exactly the type of infrastructure for which NeuroDiscovery AI works – helping the research team working with the OMOP-formatted data in a more efficient way, using AI solutions for making research based on the OMOP Common Data Model accurate and scalable, but not automating the process.

Getting Started With OMOP Data Model

Implementation for teams or health care systems implementing the OMOP CDM can be best done through a step-by-step process as follows:

1. Source Profiling - Analyze the sources of the data, their structure, the codes used, how complete they are, and their general level of maturity. Tools like WhiteRabbit could assist in profiling the sources.
2. ETL (Extract, Transform, Load) - The process of converting data from the sources to OMOP CDM format while documenting mappings and transformations made from source to target.
3. Vocabulary Mapping - Mappings of the codes used in the sources to OMOP Standardized Vocabularies using tools such as Usagi. This involves examining the mappings for accuracy and clinical relevance.
4. Validation - Validation of the transformed data against the OMOP CDM specifications and evaluation of the data using established OHDSI tools and methodologies.
5. Characterization - Analysis of the data created in OMOP CDM format for understanding the patient population and clinical characteristics. The use of tools such as ATLAS would assist in this step.
6. Analytics - Applying standard analysis processes on OMOP-standardized databases.

Final Thoughts

What, then, is the OMOP data model? OMOP stands for Observational Medical Outcomes Partnership Data Model. It is a standardized data model and terminology system that makes possible big data, multidatabase observational studies by aiding the translation of fragmented healthcare information into a uniform format. The OMOP Common Data Model was originally intended for drug safety and has become the basis of other comparative effectiveness research, real-world evidence studies, among others. Yet, standardization does not equate to ensuring data quality and clinical comparability. There is still a need to evaluate issues such as data provenance and other data quality considerations before reaching any conclusion.

As healthcare data volume and complexity continue to grow, the OMOP data model's role as shared, open, community-governed infrastructure will likely become even more central to how clinical research is conducted - and organizations like NeuroDiscovery AI that specialize in working with the OMOP common data model are positioned to help research teams unlock its full value more efficiently.

Whether a research team is just starting to evaluate what the OMOP data model is or refining a mature implementation, the underlying value proposition remains the same: standardized, reproducible, community-governed infrastructure that makes large-scale, multi-database clinical research meaningfully more efficient than working with fragmented, source-specific data alone.